Blend Labs, Inc.
NYSE:BLNDSoftware - Application
-$0.03 today
- Market cap
- $218.02M
- Beta
- 1.09
- P/E (TTM)
- -71.2
- EPS (TTM)
- -$0.02
Volume 1.19M
Average 3.92M
BLND Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Blend Labs, Inc.NYSE: BLND
Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026
Capital expenditures declines year over year
Q1 FY2026 capital expenditures of $1.12M (cash outflow) fell 75.6% year over year, behind the -34.8% change in trailing-twelve-month capital expenditures. Sequentially, it rose 11.6% from the prior quarter. Over 3 fiscal years it compounded at +77.6% a year.
Context
- Capital expenditures amounted to 9.4% of revenue in FY2025, up 3.3 pp from a year earlier.
- Capital expenditures grew in size in 2 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -75.6% toward the trailing-twelve-month pace of -34.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (11.59M) USD
- Year-over-year change
- -17.8%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (11.59M) | -17.8% |
| FY2024 | 2024-12-31 | (9.84M) | -1577.0% |
| FY2023 | 2023-12-31 | (587K) | +71.6% |
| FY2022 | 2022-12-31 | (2.07M) | -9.7% |
| FY2021 | 2021-12-31 | (1.89M) | — |
Capital Expenditures vs competitors
How BLND compares with its peers on the latest reported figures
- BLND's LTM Mar 2026 capital expenditures of $8.12M is the 5th largest of the 10 companies compared; the peer median is $3.27M.
- Its year-over-year change of -34.8% is the 8th highest of 10, against a peer median of +5.0%.
- Capital expenditures amounts to 6.4% of revenue for BLND, versus a peer median of 3.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $105.5M | +590.9% | +13.0% | 17.3% | |
| LTM Mar 2026 | $40.99M | -26.6% | +23.0% | 3.7% | |
| LTM Mar 2026 | $30.62M | +5.0% | +8.0% | 5.4% | |
| LTM Mar 2026 | $28.75M | +283.0% | +34.9% | 8.4% | |
| LTM Mar 2026 | $8.12M | -34.8% | +77.6% | 6.4% | |
| LTM Mar 2026 | $3.27M | -54.7% | -60.0% | 3.5% | |
LAESSEALSQ Corp | FY2025 | $1.24M | +117.7% | +60.8% | 6.8% |
| LTM Mar 2026 | $1.06M | -24.3% | +45.1% | 0.4% | |
| LTM Mar 2026 | $796.63K | +19.4% | -53.4% | 0.2% | |
| LTM Mar 2026 | $792.92K | -40.8% | -2.6% | 0.3% | |
| Peer median (excluding BLND) | $3.27M | +5.0% | +13.0% | 3.7% | |
Competitors are the stored peer set for BLND. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (169.14M) | (763.81M) | (179.88M) | (43.42M) | (25.97M) |
| Depreciation & Amortization | 13.81M | 14.42M | 5.76M | 4.82M | 3.82M |
| Deferred Income Tax | (39.31M) | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 70.84M | 109.7M | 46.02M | 28.08M | 28.96M |
| Change in Working Capital | (13.07M) | (4.48M) | (4.25M) | 1.89M | (2.73M) |
| Accounts Receivables | (5.84M) | 12.29M | 4.27M | 918K | 5.76M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 1.56M | (4.9M) | 910K | (67K) | 206K |
| Other Working Capital | (8.79M) | (11.87M) | (9.44M) | 1.04M | (8.7M) |
| Other Non-Cash Items | 9.36M | 453.76M | 4.73M | (4.41M) | 7.43M |
| Operating Cash Flow | (127.5M) | (190.42M) | (127.62M) | (13.04M) | 11.51M |
| Capital Expenditures | (1.89M) | (2.07M) | (587K) | (9.84M) | (11.59M) |
| Acquisitions (Net) | (400.01M) | 0 | 0 | 9.08M | 0 |
| Purchases of Investments | (354.08M) | (145.54M) | (236.08M) | (102.03M) | (35.49M) |
| Sales of Investments | 125.08M | 247.04M | 366.47M | 153.48M | 46.73M |
| Other Investing Activities | (3M) | 0 | (2.5M) | (5.28M) | 18.89M |
| Investing Cash Flow | (633.91M) | 99.43M | 127.31M | 45.4M | 18.54M |
| Debt Repayment | 221.67M | 0 | (85.06M) | (144.5M) | 0 |
| Common Stock Issued | 366.81M | 0 | 268K | 0 | 1.65M |
| Common Stock Repurchased | 0 | (391K) | 0 | 0 | (24.87M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 35.39M | 2.61M | (6.17M) | (25.94M) | (9.37M) |
| Financing Cash Flow | 933.57M | 2.22M | (90.96M) | (21.06M) | (32.59M) |
| Effect of Forex Changes | (9K) | (116K) | (31K) | (5K) | (1.15M) |
| Net Change in Cash | 172.15M | (88.88M) | (91.3M) | 11.28M | (3.69M) |
| Free Cash Flow | (129.39M) | (192.49M) | (128.21M) | (22.89M) | (81K) |
Blend Labs, Inc.
NYSE:BLND
Intrinsic Alpha fair value
Locked
Current Price
$0.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.